M P López Cabrerizo - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Current Opinion in Oncology|March 1, 1997

Preoperative chemotherapy for stage IIIA non-small cell lung cancerR Rosell, M P López-Cabrerizo, J Astudillo

Medicina Clinica|February 14, 1998

[Positron emission tomography detection of residual disease in a case of lung cancer]R Rosell, M P López Cabrerizo, J Maurel, et al.

Medicina Clinica|May 31, 1997

[Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung]M Sánchez Céspedes, M P López Cabrerizo, I Moreno, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998

Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patientsM Sánchez-Céspedes, M Monzó, R Rosell, et al.

Revista Clinica Espanola|April 29, 1998

[Classical Kaposi sarcoma of aggressive course]M Just Sarobé, M Ribera Pibernat, M P López Cabrerizo, et al.

Seminars in Oncology|August 1, 1997

A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancerR Rosell, E Felip, B Massuti, et al.

International Journal of Cancer|June 20, 1997

Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errorsR Rosell, A Pifarré, M Monzó, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997

Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancerM Sánchez-Céspedes, R Rosell, A Pifarré, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998

Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trialsE Felip, B Massuti, C Camps, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancerF Cardenal, M P López-Cabrerizo, A Antón, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Current Opinion in Oncology|March 1, 1997

Preoperative chemotherapy for stage IIIA non-small cell lung cancerR Rosell, M P López-Cabrerizo, J Astudillo

Medicina Clinica|February 14, 1998

[Positron emission tomography detection of residual disease in a case of lung cancer]R Rosell, M P López Cabrerizo, J Maurel, et al.

Medicina Clinica|May 31, 1997

[Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung]M Sánchez Céspedes, M P López Cabrerizo, I Moreno, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998

Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patientsM Sánchez-Céspedes, M Monzó, R Rosell, et al.

Revista Clinica Espanola|April 29, 1998

[Classical Kaposi sarcoma of aggressive course]M Just Sarobé, M Ribera Pibernat, M P López Cabrerizo, et al.

Seminars in Oncology|August 1, 1997

A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancerR Rosell, E Felip, B Massuti, et al.

International Journal of Cancer|June 20, 1997

Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errorsR Rosell, A Pifarré, M Monzó, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997

Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancerM Sánchez-Céspedes, R Rosell, A Pifarré, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998

Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trialsE Felip, B Massuti, C Camps, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancerF Cardenal, M P López-Cabrerizo, A Antón, et al.

Pageof 1